Cullinan Oncology
Cullinan Oncology
cullinanoncology.com

Locations

Cambridge, MA, USA

industry

Biotechnology · DeepTech · Finance · Health

Size

51-200 employees

Stage

Series A

founded in

2017

Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.

Something looks off?
Open jobs at Cullinan Oncology

On-site & Remote